Buy Azathioprine
Azathioprine

$0.85
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Azathioprine Properties

Active Ingredients
Pharmacological Class
Purine Antimetabolite, Immunosuppressant
Minor Side Effects
Dosage Forms
Tablets
Administration Route
Oral
Mechanism of Action
Azathioprine works by suppressing the body's immune system. It reduces the activity of immune cells, which helps to prevent the immune system from attacking healthy tissues in autoimmune diseases or transplanted organs.
Prescription Status
Rx
Patient Summary
Azathioprine is an immunosuppressant medication used to treat severe autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease, and to prevent organ rejection after transplantation.
Onset Time
Weeks to months
Duration
Daily dosing
Storage Instructions
Store at room temperature, away from light and moisture
Age Restrictions
For adult use, and children under strict medical supervision for certain conditions
Pregnancy Use
Avoid use during pregnancy or breastfeeding due to potential harm to fetus/infant

About Azathioprine

Generic Azathioprine is an oral immunosuppressant used primarily to curb the overactive immune response seen in autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease, as well as to prevent rejection after organ transplantation. The active ingredient, azathioprine, belongs to the antimetabolite class and functions by interfering with DNA synthesis in rapidly dividing lymphocytes. In Australia, it is listed as a prescription-only medicine (Schedule 4) and is typically prescribed in 25 mg or 50 mg tablets. While its main indications are well established, clinicians sometimes consider it for off-label conditions when conventional therapies are inadequate.

What is Generic Azathioprine?

Generic Azathioprine is a synthetic purine analogue that has been approved by the Therapeutic Goods Administration (TGA) for the treatment of several autoimmune conditions and for prophylaxis of graft rejection in solid-organ transplants. First registered in the early 1960s, the drug is marketed globally under various brand names, but the generic formulation contains the same active molecule and meets the same bio-equivalence standards. In Australia it is supplied only with a physician’s prescription and is classified as a Schedule 4 agent. The medication is available as film-coated tablets in strengths of 25 mg and 50 mg, intended for oral ingestion.

How Azathioprine Works

Azathioprine is a pro-drug that is rapidly converted in the liver to 6-mercaptopurine (6-MP). 6-MP is then metabolised by several enzymatic pathways, most notably by thiopurine methyltransferase (TPMT) and hypoxanthine-guanine phosphoribosyltransferase (HGPRT). The HGPRT route yields thio-inosine-monophosphate (TIMP), which inhibits de novo purine synthesis, leading to reduced formation of guanosine nucleotides. Lymphocytes, which rely heavily on the salvage pathway for nucleotide production, are especially vulnerable; their proliferation slows dramatically. By dampening T-cell and B-cell expansion, azathioprine diminishes the immune attack on self-tissues in autoimmune disease and curtails the allo-immune response that drives transplant rejection.

Pharmacokinetically, azathioprine is well absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 1-2 hours. Oral bioavailability ranges from 50 % to 80 %, depending on individual TPMT activity. The drug’s half-life is roughly 5 hours, but the immunosuppressive effect persists for weeks because lymphocyte turnover is gradual. Metabolism produces both active and inactive metabolites, with renal excretion accounting for most clearance. Genetic testing for TPMT deficiency is recommended before initiation, as reduced enzyme activity can precipitate severe bone-marrow toxicity.

Why Azathioprine is Used for Autoimmune Disorders, Transplant Medicine Conditions

  • Rheumatoid Arthritis - By limiting synovial lymphocyte proliferation, azathioprine reduces joint inflammation and slows erosive damage. It is positioned as a second-line agent when methotrexate or biologics are contraindicated or insufficient.
  • Inflammatory Bowel Disease (Crohn’s and Ulcerative Colitis) - The drug attenuates the mucosal immune response, promoting remission in patients who fail corticosteroids or anti-TNF therapy. Guidelines endorse azathioprine as a maintenance therapy after induction of remission.
  • Systemic Lupus Erythematosus - Suppression of auto-antibody producing B-cells helps control serositis, renal involvement, and hematologic abnormalities. It is often combined with hydroxychloroquine or low-dose steroids.
  • Organ Transplantation (Kidney, Liver, Heart) - Azathioprine forms part of multi-drug regimens with calcineurin inhibitors and steroids, providing a dose-sparing effect that reduces nephrotoxicity. It is valued for its long-term safety profile compared with newer agents.
  • Dermatologic Autoimmune Conditions (e.g., Pemphigus vulgaris) - The drug curbs auto-antibody production against skin desmogleins, allowing tapering of high-dose steroids.

In each case, the drug’s capacity to halt lymphocyte expansion directly targets the pathogenic mechanism of the disease, explaining its recurring presence in treatment algorithms. Compared with newer biologics, azathioprine offers a lower acquisition cost and a well-characterised safety record, making it a viable first- or second-line option in many Australian clinical pathways.

Off-Label and Investigational Uses of Azathioprine

Azathioprine has been explored in several conditions where immune modulation is desirable but formal approval is lacking in Australia. Small-scale randomized trials and cohort studies suggest benefit in autoimmune hepatitis, where it may reduce transaminase elevations when combined with steroids. Case series have reported remission in vasculitic disorders such as granulomatosis with polyangiitis, and experimental data hint at utility in multiple sclerosis as an adjunct to interferon-β therapy. These investigations remain limited in size and duration, and the drug is not licensed for these indications by the TGA.

Off-label use should only be considered under the supervision of a qualified healthcare provider.

Is Azathioprine Right for You?

Azathioprine suits adults who require sustained immune suppression and can adhere to regular laboratory monitoring. Ideal candidates include patients with moderate-to-severe rheumatoid arthritis who have exhausted methotrexate, individuals with chronic inflammatory bowel disease seeking steroid-sparing maintenance, and organ-transplant recipients needing a stable, cost-effective component of their immunosuppressive regimen.

Special populations demand caution: patients with known TPMT deficiency, significant hepatic impairment, or active infections are generally excluded. Pregnant or breastfeeding women should only use azathioprine after a thorough risk-benefit discussion, as the drug crosses the placenta but does not appear to increase major congenital anomalies. Elderly patients may require lower doses because renal clearance declines with age.

As noted in the medication information, contraindications include severe bone-marrow suppression, uncontrolled infections, and hypersensitivity to thiopurines. If any of these circumstances apply, alternative immunosuppressants should be explored.

Taking Azathioprine Effectively

Azathioprine is taken orally, usually once daily with a glass of water. Food does not markedly affect absorption, but a consistent routine helps maintain stable plasma levels. Because the drug’s effect may take several weeks to manifest, patients should not expect immediate symptom relief; clinicians often assess response after 8-12 weeks.

If a dose is missed, the recommendation is to take it as soon as remembered unless it is close to the next scheduled dose; in that case, skip the missed tablet and resume the regular schedule to avoid double dosing. Routine laboratory monitoring-complete blood count, liver function tests, and TPMT activity-should be performed at baseline, then every 2-4 weeks for the first three months, and subsequently every 3-6 months.

Traveling abroad does not require dosage adjustment, but patients should carry a copy of the prescription and a summary of their monitoring schedule. Alcohol consumption should be limited, as it may exacerbate hepatic toxicity.

Understanding Side Effects and How to Manage Them

The most common adverse events stem from the drug’s impact on rapidly dividing cells. Bone-marrow suppression-manifesting as leukopenia, anemia, or thrombocytopenia-occurs because progenitor cells in the marrow are sensitive to purine synthesis inhibition. Regular CBC monitoring enables early detection; dose reduction or temporary cessation usually resolves cytopenias.

Hepatotoxicity arises from the accumulation of methylated metabolites in the liver. Elevations in transaminases are often mild and reversible, but persistent rises warrant dose adjustment and, in severe cases, discontinuation. Patients should avoid excessive alcohol and inform their clinician of any concomitant hepatotoxic drugs.

Gastrointestinal discomfort (nausea, vomiting, abdominal pain) is related to local irritation of the mucosa. Taking the tablet with food or a small antacid can mitigate these symptoms.

Infection risk is a direct consequence of immune suppression. Patients should report fevers, persistent cough, or skin lesions promptly and practice standard infection-prevention measures (hand hygiene, appropriate vaccinations).

Rare but serious events include pancreatitis and an increased long-term risk of malignancies such as lymphomas and non-melanoma skin cancers. Any sudden, severe abdominal pain or unexplained weight loss should trigger immediate medical evaluation.

If side effects become intolerable or laboratory abnormalities persist despite dose modifications, clinicians may switch to alternative agents such as mycophenolate mofetil or biologic therapies.

Buying Azathioprine from Our Online Pharmacy

Accessing azathioprine can be challenging, especially for patients living in remote regions of Australia or those whose insurance plans limit coverage for immunosuppressants. Our online pharmacy offers a discreet, reliable way to obtain the medication at competitive prices, while ensuring that every batch meets the strict quality standards required by the TGA.

Why Choose Our Service?

  • Convenient Access: Order from any device and have the medication delivered directly to your door, eliminating the need for multiple pharmacy visits.
  • Secure Transactions: All payments are encrypted, and personal data is stored in compliance with Australian privacy regulations.

Quality & Safety

We partner with licensed international pharmacies that operate under stringent regulatory frameworks and WHO-GMP standards. Each shipment includes a certificate of analysis confirming the product’s potency and purity.

Pricing & Access

Generic azathioprine is substantially less expensive than brand-name equivalents, delivering up-to-80 % savings on the standard 25 mg and 50 mg tablets. For returning customers we provide a lifetime 10 % discount on all reorders, helping maintain long-term therapy without financial strain.

Discreet Delivery

Orders are packaged in neutral, tamper-evident containers. Express shipping typically arrives within 7 days, while standard delivery may take up to three weeks, both with full tracking.

Frequently Asked Questions

  • What monitoring is required while taking azathioprine? Blood counts and liver function tests are checked every 2-4 weeks during the initial treatment phase, then every 3-6 months once stable. TPMT testing before start helps tailor the dose and avoid severe toxicity.

  • Can I take azathioprine if I have a viral infection? Active infections are a contraindication because further immune suppression could worsen the condition. Treat the infection first, then re-evaluate the need for azathioprine.

  • Is azathioprine safe during pregnancy? The drug crosses the placenta but current evidence does not show a marked increase in major congenital anomalies. Use only when the therapeutic benefit outweighs potential risks, under close obstetric supervision.

  • How does azathioprine compare to mycophenolate mofetil for transplant patients? Both are antimetabolites, yet mycophenolate generally provides stronger lymphocyte inhibition and may be preferred in high-risk grafts. Azathioprine, however, offers lower cost and a longer track record of tolerability.

  • Why do some patients experience nausea after the first dose? Early gastrointestinal irritation is common as the drug reaches high plasma concentrations. Taking the tablet with food or a mild antacid often reduces this effect.

  • Can I stop azathioprine abruptly if I feel better? Sudden discontinuation can precipitate disease flare or, in transplant recipients, acute rejection. Dose tapering under medical guidance is essential.

  • Are there any dietary restrictions while on azathioprine? Limit alcohol intake to protect liver health and avoid excessive intake of purine-rich foods, which could theoretically increase metabolite load, though the effect is modest.

  • What should I do if I miss a dose? If more than 12 hours have passed, skip the missed tablet and resume the regular schedule. Taking two doses close together raises the risk of toxicity.

  • Is vitamin supplementation needed? Folate or vitamin B12 deficiency can exacerbate cytopenias; some clinicians prescribe low-dose folic acid alongside azathioprine, especially when methotrexate is also used.

  • How long does it take to see clinical improvement? Therapeutic effects usually emerge after 8-12 weeks, reflecting the time needed for lymphocyte turnover reduction. Patience and regular monitoring are key.

  • Can azathioprine be combined with biologic agents? Combination therapy is sometimes employed in severe autoimmune disease, but it increases infection risk and requires vigilant laboratory surveillance.

Glossary

Antimetabolite
A class of drugs that mimic natural metabolites, disrupting essential biochemical pathways-in this case, purine synthesis-to inhibit cell proliferation.
Thiopurine Methyltransferase (TPMT)
An enzyme that metabolises thiopurine drugs; genetic variations affect drug toxicity, making TPMT testing a standard pre-treatment step.
Lymphocyte Proliferation
The process by which T-cells and B-cells multiply in response to antigenic stimulation; suppression of this process underlies azathioprine’s immunosuppressive action.

Disclaimer

The information provided about Generic Azathioprine is intended for general educational purposes only and does not substitute professional medical consultation. All decisions regarding treatment, including any off-label applications, should be made under the supervision of a qualified healthcare provider. Readers are assumed to be responsible adults capable of making informed health choices. Our online pharmacy offers access to azathioprine for individuals who may face limited availability through conventional pharmacies or who seek affordable generic alternatives. Always discuss with your doctor before initiating, modifying, or discontinuing any medication.

External Resources about Azathioprine


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD